On July 2, 2020, National Medical Products Administration and National Health Commission issued an announcement on the 2020 Edition of the Pharmacopoeia of the People's Republic of China, of which the contents are as follows:

According to the Drug Administration Law of the People's Republic of China, the 2020 Edition of the Pharmacopoeia of the People's Republic of China reviewed and approved at the plenary meeting of the executive committee of the Eleventh Chinese Pharmacopoeia Commission (ChP) was issued on June 24, 2020, and shall come into force as of December 30, 2020.